Investigator Studies Program (MISP): Rotavirus
Effective December 2017, the Rotavirus Investigator Studies Program (MISP) Committee will accept proposals within our current areas of interest (AOI) up to May 1, 2018. This is a competitive process that will be conducted by the Rotavirus MISP in 2018. Decisions will be made on the basis of scientific merit and strategic fit within the AOI. Please review the critical activities and abide by the timelines as outlined below

The following areas are of interest to Investigator Studies Program Committee:
  • Investigation of strategies aiming to improve vaccine efficacy of RotaTeq™ in low income settings
  • Studies to assess the reduction of gastroenteritis in areas where RotaTeq™ is widely used, where there is reasonable health care infrastructure to assess changes in disease burden, and where such data are currently limited.
  • Investigate indirect health benefits to RotaTeq™ vaccine

Please complete a full protocol and detailed budget via Visiontracker, the Company's on-line study management system (in US) or your MSD country representative (outside US). The proposals will be collectively reviewed and selected by the Rotavirus MISP Committee.


Critical Activities and Timelines:
Activity 1st Review Cycle
Full Protocol Submission with Detailed Budget May 1, 2018
Final Comments to Investigator July 9, 2018


MISP Information
This site is intended for US investigators only. Investigators outside of the US interested in submitting research proposals to the Investigator Studies Program should contact their local MSD office.